• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA RADIFOCUS GLIDECATH HYDROPHILIC COATED CATH; CATHETER, INTRAVASCULAR, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA RADIFOCUS GLIDECATH HYDROPHILIC COATED CATH; CATHETER, INTRAVASCULAR, DIAGNOSTIC Back to Search Results
Model Number N/A
Device Problem Break (1069)
Patient Problem Foreign Body In Patient (2687)
Event Date 09/29/2023
Event Type  Injury  
Event Description
Terumo medical received an fda medwatch report # mw (b)(4).The event description states that during an aortogram with left leg angiogram a 4fr angled glide catheter broke, leaving a large remanent in the patient.The catheter was appropriately flushed pre-op during procedure set up and no damage was noted.When the md advanced the glidewire advantage through the catheter, he felt a snap and tried to pull the catheter out, that's when he noticed the catheter had broken off.An aortogram was performed, and a remanent piece of the catheter was able to be snared out.The catheter and remaining remanent were placed in biohazard bag and given to assistant manager as this appears to be a manufacturer issue.The original intended procedure was an ultrasound-guided access of bilateral common femoral arteries, nonselective catheter placement aorta times two.Stenting of bilateral common iliac arteries using an 8 x 37 visi pro stent on the left and an 8 x 27 visi pro stent on the right was performed.Percutaneous closure of bilateral common femoral arteries using two, 6 french angio-seals was done.The device did not function as intended.(e.G., broke, could not get it to work or stopped working).Additional information was received on 01nov2023: the patient was stable, and the procedure was able to be completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RADIFOCUS GLIDECATH HYDROPHILIC COATED CATH
Type of Device
CATHETER, INTRAVASCULAR, DIAGNOSTIC
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
MDR Report Key18182001
MDR Text Key328741690
Report Number2243441-2023-00043
Device Sequence Number1
Product Code DQO
UDI-Device Identifier04987350772190
UDI-Public04987350772190
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Nurse
Type of Report Initial
Report Date 11/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberCG415
Device Lot Number230322
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA11/21/2023
Distributor Facility Aware Date10/30/2023
Device Age6 MO
Event Location Hospital
Date Report to Manufacturer10/31/2023
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
2 6 FRENCH ANGIO-SEALS; 8 X 27 VISI PRO STENT; 8 X 37 VISI PRO STENT
Patient Outcome(s) Required Intervention; Other;
-
-